About Sai Life Sciences:
The company operates as a fully integrated, innovator-focused organization specializing in contract research, development, and manufacturing. It offers comprehensive, end-to-end services across the drug discovery, development, and manufacturing value chain for small molecule new chemical entities, catering to global pharmaceutical innovators and biotechnology firms. The company combines capabilities in both discovery/contract research and chemistry, manufacturing, and control (CMC)/contract development and manufacturing organization (CDMO). Its research laboratories for discovery and development are strategically located near innovation hubs in Watertown (Greater Boston, MA), US, and Manchester, UK, complemented by large-scale research laboratories and manufacturing facilities in cost-competitive locations in India.
About the Industry in which Sai Life Sciences operates:
The global small molecule contract research, development, and manufacturing organization (CRDMO) industry is projected to reach USD 159 billion by 2028, accounting for approximately 53% of the overall global CRDMO market. This growth is driven by increasing outsourcing of pharmaceutical and biotech research and development, sustained demand for small molecules, and rising demand for cost-effective drugs. The Indian CRDMO market, one of the fastest-growing in the Asia-Pacific region from 2018 to 2023, is expected to expand at a compound annual growth rate (CAGR) of 14.0% between 2023 and 2028, reaching an estimated value of USD 14.1 billion by 2028.
| Important Information and Timelines of the IPO of Sai Life Sciences: | |
|---|---|
| Open Date | 11 December 2024 |
| Close Date | 13 December 2024 |
| Total Issue Size – Number of Shares | 55421123 |
| Minimum Bid Price | 522 |
| Maximum Bid Price | 549 |
| Lot Size | 27 |
| Basis of Allotment | 16 December 2024 |
| Initiation of Refunds and Credit of Shares to Demat | 17 December 2024 |
| Listing Date | 18 December 2024 |
| Listing Exchange(s) | NSE and BSE |
Minimum and Maximum Lot Sizes for the IPO of Sai Life Sciences:
| Category | Lots | Shares | Amount (in ₹) |
|---|---|---|---|
| Retail – Minimum | 1 | 27 | 14823 |
| Retail – Maximum | 13 | 351 | 192699 |
| sHNI – Minimum | 14 | 378 | 207522 |
| sHNI – Maximum | 67 | 1809 | 993141 |
| bHNI – Minimum | 68 | 1836 | 1007964 |
Objective of the IPO of Sai Life Sciences:
The IPO aims to:
-
Repay or prepay, either partially or fully, certain outstanding borrowings of the company.
-
Fund general corporate purposes.
Financials of Sai Life Sciences:
Here is the tabulated data:
| Particulars | As at and for the six months period ended September 30, 2024 | As at and for the six months period ended September 30, 2023 | As at and for the Financial Year ended March 31, 2024 | As at and for the Financial Year ended March 31, 2023 | As at and for the Financial Year ended March 31, 2022 |
|---|---|---|---|---|---|
| Equity share capital | 188.79 | 180.17 | 180.50 | 180.10 | 179.43 |
| Total income | 6,933.50 | 6,568.00 | 14,942.69 | 12,451.05 | 8,977.41 |
| Profit/(Loss) for the year(7) | 280.12 | (129.24) | 828.09 | 99.89 | 62.26 |
| *Basic earnings per equity share (in ₹)(1)(2) | 1.50 | (0.71) | 4.57 | 0.55 | 0.35 |
| *Diluted earnings per equity share (in ₹)(1)(2) | 1.49 | (0.71) | 4.53 | 0.55 | 0.34 |
| Total borrowings(3) | 7,644.86 | 6,791.97 | 7,101.63 | 6,992.29 | 7,513.18 |
| Net Worth(4) | 10,447.51 | 8,749.86 | 9,743.37 | 8,872.86 | 8,777.58 |
| *Return on Net Worth(5) (%) ** | 2.68% | (1.48%) | 8.50 | 1.13 | 0.71 |
| Net Asset Value per Equity Share(6) (in ₹) | 55.93 | 48.37 | 53.83 | 49.18 | 48.90 |
For more details on the IPO, refer to the DRHP here.
Did you know that you can now Pre-Apply for an IPO on Dhan? You can place your IPO Bid on Dhan and the order will be pushed to the Exchange as soon as the Bidding starts for Sai Life Sciences. You will receive a UPI mandate after 10:00 AM on 11 December 2024.
###1. How to apply for the IPO of Sai Life Sciences on Dhan?
You can apply for the IPO of Sai Life Sciences from either Dhan Mobile App or Web
On Dhan Mobile App you can find the IPO under the Money Section > IPO Tab
On Dhan Web you can find the IPO under Markets Tab > IPOs
###2. In case of successful allotment, when the IPO shares of Sai Life Sciences be visible on Dhan?
The CDSL will intimate you regarding the credit of shares into your Demat account by 17 December 2024. However, you will be able to see the shares of Sai Life Sciences on Dhan before the market starts on the listing date which is 18 December 2024.